VM Pharma (TrkA Program) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
VM Pharma (TrkA Program) General Information
Description
VM-902A pharmaceutical product. The asset is used to develop VM-902A which is orally bioavailable, peripherally acting and allosteric selective tropomyosin receptor kinase for recovering of many diseases in USA.
Contact Information
Corporate Office
- 45535 Northport Loop East
- Fremont, CA 94538
- United States
Corporate Office
- 45535 Northport Loop East
- Fremont, CA 94538
- United States
VM Pharma (TrkA Program) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
VM Pharma (TrkA Program) FAQs
-
Where is VM Pharma (TrkA Program) headquartered?
VM Pharma (TrkA Program) is headquartered in Fremont, CA.
-
What industry is VM Pharma (TrkA Program) in?
VM Pharma (TrkA Program)’s primary industry is Buildings and Property.
-
Is VM Pharma (TrkA Program) a private or public company?
VM Pharma (TrkA Program) is a Private company.
-
What is the current valuation of VM Pharma (TrkA Program)?
The current valuation of VM Pharma (TrkA Program) is .
-
What is VM Pharma (TrkA Program)’s current revenue?
The current revenue for VM Pharma (TrkA Program) is .
-
When was VM Pharma (TrkA Program) acquired?
VM Pharma (TrkA Program) was acquired on 08-Sep-2015.
-
Who acquired VM Pharma (TrkA Program)?
VM Pharma (TrkA Program) was acquired by Knoa Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process